Summary
- Current Price
- As of today, MNPR price is $108.35, down -5.50% on
- Current Price All-Time High
- MNPR price is currently -54.85% below its historical high of $240.00 set on
- Market Cap
- MNPR current market cap is $726M, up +187.66% over the past 365 days
- Revenue
- MNPR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for MNPR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Monopar Therapeutics Inc. |
| Ticker | NASDAQ: MNPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | monopartx.com |
| Employees | 14 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $108.35 | |
| Price, 1D Change | -5.50% | |
| $726M | ||
| - | ||
| - | ||
| 1.54 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.85 | ||
| EPS, 1Y Change | +54.99% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.85 | ||
| EPS Estimate | N/A | -$2.90 |
| EPS Est. Change | N/A | -56.89% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $108.35 | |
| Price Target | - | $117.00 |
| Price Tgt. Change | - | +7.98% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.77 | -$4.11 | -131.90% | |
| -$1.67 | -$1.85 | -10.67% | |
| -$2.90 | N/A | -56.89% | |
| -$3.14 | N/A | -69.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $15.84M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $108.35 | |
| $71.04 | ||
| $84.68 | ||
| $69.60 | ||
| $90.16 | ||
| $7.20 | ||
| 1.54 | ||
| $7.62 | ||
| 58.31 | ||
| 76.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.85 | ||
| $0.00 | ||
| - | ||
| -$16.70M | ||
| - | ||
| -$13.72M | ||
| - | ||
| -$16.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 51.35 | ||
| 51.35 | ||
| - | ||
| - | ||
| 150.97 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.36 | ||
| -31.46 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $137.83M | ||
| $140.40M | ||
| $140.72M | ||
| $140.46M | ||
| $2.89M | ||
| $2.74M | ||
| $154.90K | ||
| $0.00 | ||
| $2.74M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $13.72M | ||
| $16.70M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.20M | ||
| -$63.45M | ||
| $91.57M | ||
| $0.00 | ||
| -$12.20M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| BTIG | → | |
| BTIG | → | |
| Chardan Capital | → | |
| BTIG | → | |
| Morgan Stanley | ||
| Raymond James | → |
Analyst sentiment
Institutional ownership
Screeners with MNPR
FAQ
- What is the ticker symbol for Monopar Therapeutics Inc.?
- The ticker symbol for Monopar Therapeutics Inc. is NASDAQ:MNPR
- Does Monopar Therapeutics Inc. pay dividends?
- No, Monopar Therapeutics Inc. does not pay dividends
- What sector is Monopar Therapeutics Inc. in?
- Monopar Therapeutics Inc. is in the Healthcare sector
- What industry is Monopar Therapeutics Inc. in?
- Monopar Therapeutics Inc. is in the Biotechnology industry
- What country is Monopar Therapeutics Inc. based in?
- Monopar Therapeutics Inc. is headquartered in United States
- When did Monopar Therapeutics Inc. go public?
- Monopar Therapeutics Inc. initial public offering (IPO) was on December 19, 2019
- Is Monopar Therapeutics Inc. in the S&P 500?
- No, Monopar Therapeutics Inc. is not included in the S&P 500 index
- Is Monopar Therapeutics Inc. in the NASDAQ 100?
- No, Monopar Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Monopar Therapeutics Inc. in the Dow Jones?
- No, Monopar Therapeutics Inc. is not included in the Dow Jones index
- When was Monopar Therapeutics Inc. last earnings report?
- Monopar Therapeutics Inc.'s most recent earnings report was on May 14, 2026
- When does Monopar Therapeutics Inc. report earnings?
- The next expected earnings date for Monopar Therapeutics Inc. is August 13, 2026
Data Sources & References
- MNPR Official Website www.monopartx.com
- MNPR Profile on Yahoo Finance finance.yahoo.com/quote/MNPR
- MNPR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mnpr